• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性头颈部肿瘤患者的血清免疫抑制酸性蛋白(IAP)

Serum immunosuppressive acidic protein (IAP) in patients with malignant head and neck tumors.

作者信息

Yokode Y, Furusaka T, Kida A, Tomita H

出版信息

Auris Nasus Larynx. 1985;12 Suppl 2:S221-5. doi: 10.1016/s0385-8146(85)80063-8.

DOI:10.1016/s0385-8146(85)80063-8
PMID:3879742
Abstract

Measurements were carried out on the serum immunosuppressive acidic protein (IAP) level of patients with malignant head and neck tumors. The serum IAP value in patients with malignancies was significantly higher than that in healthy subjects and those with benign tumors. Following treatment, in cases with favorable progress the high IAP values prior to treatment showed a decline, becoming normal. Whereas in cases showing poor progress, there was a delay in reverting to normal values and some were observed to retain the same high values.

摘要

对恶性头颈部肿瘤患者的血清免疫抑制酸性蛋白(IAP)水平进行了测量。恶性肿瘤患者的血清IAP值显著高于健康受试者和良性肿瘤患者。治疗后,病情进展良好的病例中,治疗前较高的IAP值出现下降,恢复正常。而在病情进展不佳的病例中,恢复正常水平出现延迟,且观察到一些病例仍保持较高值。

相似文献

1
Serum immunosuppressive acidic protein (IAP) in patients with malignant head and neck tumors.恶性头颈部肿瘤患者的血清免疫抑制酸性蛋白(IAP)
Auris Nasus Larynx. 1985;12 Suppl 2:S221-5. doi: 10.1016/s0385-8146(85)80063-8.
2
Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients.头颈癌患者免疫抑制酸性蛋白及其他免疫学参数的调查
J Laryngol Otol. 1991 Nov;105(11):939-45. doi: 10.1017/s0022215100117864.
3
[Clinical evaluation of immunosuppressive factors (IAP-immunosuppressive acidic protein, IS-immunosuppressive substance) in head and neck cancer].[头颈部癌症中免疫抑制因子(IAP-免疫抑制酸性蛋白,IS-免疫抑制物质)的临床评估]
Nihon Jibiinkoka Gakkai Kaiho. 1989 Apr;92(4):588-96. doi: 10.3950/jibiinkoka.92.588.
4
[Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].[恶性肿瘤患者血清免疫抑制酸性蛋白(IAP)和酸溶性糖蛋白(ASP)的临床评估]
Shigaku. 1989 Aug;77(2):701-11.
5
Immunosuppressive substance in the sera of head and neck cancer patients.
Cancer. 1988 Oct 1;62(7):1293-8. doi: 10.1002/1097-0142(19881001)62:7<1293::aid-cncr2820620708>3.0.co;2-d.
6
[The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].[胃癌患者血清免疫抑制酸性蛋白(IAP)与细胞免疫的关系]
Gan To Kagaku Ryoho. 1982 Oct;9(10):1827-31.
7
[Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Gan To Kagaku Ryoho. 1982 Oct;9(10):1755-64.
8
[Studies on immunosuppressive acidic protein (IAP) in ovarian tumors].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jun;37(6):923-9.
9
Immunosuppressive acidic protein in patients with ovarian cancer.
Cancer. 1983 Dec 1;52(11):2081-5. doi: 10.1002/1097-0142(19831201)52:11<2081::aid-cncr2820521119>3.0.co;2-t.
10
[Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].妇科恶性肿瘤中的免疫抑制酸性蛋白(IAP)及其与其他免疫抑制物质和细胞介导免疫的关系
Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt):237-44.